Search Results

There are 11274 results for: content related to: Glucocorticoid therapy-induced skin atrophy

  1. You have free access to this content
    Shortened treatment duration of glucocorticoid-induced skin atrophy in rats

    Experimental Dermatology

    Volume 20, Issue 10, October 2011, Pages: 853–855, Stefanie Schoepe, Richardus Vonk, Heike Schäcke, Thomas M. Zollner, Khusru Asadullah and Lars Röse

    Version of Record online : 8 AUG 2011, DOI: 10.1111/j.1600-0625.2011.01341.x

  2. You have free access to this content
    Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases

    British Journal of Pharmacology

    Volume 158, Issue 4, October 2009, Pages: 1088–1103, H Schäcke, TM Zollner, WD Döcke, H Rehwinkel, S Jaroch, W Skuballa, R Neuhaus, E May, U Zügel and K Asadullah

    Version of Record online : 7 MAY 2009, DOI: 10.1111/j.1476-5381.2009.00238.x

  3. Superior nuclear receptor selectivity and therapeutic index of methylprednisolone aceponate versus mometasone furoate

    Experimental Dermatology

    Volume 16, Issue 9, September 2007, Pages: 753–761, Parham Mirshahpanah, Wolf-Dietrich Döcke, Udo Merbold, Khusru Asadullah, Lars Röse, Heike Schäcke and Thomas M. Zollner

    Version of Record online : 9 AUG 2007, DOI: 10.1111/j.1600-0625.2007.00597.x

  4. Skin atrophogenic potential of methylprednisolone aceponate (MPA)

    Journal of the European Academy of Dermatology and Venereology

    Volume 3, Issue s1, April 1994, Pages: S13–S18, J.P. Ortonne

    Version of Record online : 2 FEB 2011, DOI: 10.1111/j.1468-3083.1994.tb01058.x

  5. Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy

    Journal of the European Academy of Dermatology and Venereology

    Volume 26, Issue s3, May 2012, Pages: 47–51, E. Castela, E. Archier, S. Devaux, A. Gallini, S. Aractingi, B. Cribier, D. Jullien, F. Aubin, H. Bachelez, P. Joly, M. Le Maître, L. Misery, M.-A. Richard, C. Paul and J.P. Ortonne

    Version of Record online : 18 APR 2012, DOI: 10.1111/j.1468-3083.2012.04523.x

  6. Topical administration of the pan-Src kinase inhibitors, dasatinib and LCB 03-0110, prevents allergic contact dermatitis in mice

    British Journal of Dermatology

    Volume 168, Issue 1, January 2013, Pages: 112–119, S.H. Jung, X. Sun, W.-S. Ryu and B.-S. Yang

    Version of Record online : 21 DEC 2012, DOI: 10.1111/bjd.12069

  7. The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study

    British Journal of Dermatology

    Volume 144, Issue 3, February 2001, Pages: 507–513, C. Queille-Roussel, C. Paul, L. Duteil, M-C. Lefebvre, G. Rapatz, M. Zagula and J-P. Ortonne

    Version of Record online : 23 DEC 2001, DOI: 10.1046/j.1365-2133.2001.04076.x

  8. Corticosteroid skin atrophogenicity: assessment methods

    Skin Research and Technology

    Volume 4, Issue 4, November 1998, Pages: 161–166, J. Y. Lee and H. I. Maibach

    Version of Record online : 27 OCT 2006, DOI: 10.1111/j.1600-0846.1998.tb00104.x

  9. You have free access to this content
    Suppression of hyaluronan synthase 2 expression reflects the atrophogenic potential of glucocorticoids

    Experimental Dermatology

    Volume 19, Issue 8, August 2010, Pages: 757–759, Marco Averbeck, Carl Gebhardt, Ulf Anderegg and Jan C. Simon

    Version of Record online : 21 JUL 2010, DOI: 10.1111/j.1600-0625.2010.01099.x

  10. You have free access to this content
    Inhibition of glucocorticoid-induced epidermal and dermal atrophy with KH 1060 – a potent 20-epi analogue of 1,25-dihydroxyvitamin D3

    British Journal of Pharmacology

    Volume 113, Issue 2, October 1994, Pages: 439–444, Robert Gniadecki, Monika Gniadecka and Jørgen Serup

    Version of Record online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1994.tb17008.x

  11. You have free access to this content
    Topical treatments for chronic plaque psoriasis

    Intervention Review

    The Cochrane Library

    Anne R Mason, James Mason, Michael Cork, Gordon Dooley and Helen Hancock

    Published Online : 28 MAR 2013, DOI: 10.1002/14651858.CD005028.pub3

  12. Glucocorticoid action on skin collagen: overview on clinical significance and consequences

    Journal of the European Academy of Dermatology and Venereology

    Volume 15, Issue 4, July 2001, Pages: 361–362, P Nuutinen, P Autio, T Hurskainen and A Oikarinen

    Version of Record online : 15 AUG 2008, DOI: 10.1046/j.0926-9959.2001.00272-4.x

  13. You have free access to this content
    Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index

    Experimental Dermatology

    Volume 15, Issue 8, August 2006, Pages: 565–573, Heike Schäcke, Hartmut Rehwinkel, Khusru Asadullah and Andrew C. B. Cato

    Version of Record online : 28 JUN 2006, DOI: 10.1111/j.1600-0625.2006.00453.x


    Australasian Journal of Dermatology

    Volume 32, Issue 2, August 1991, Pages: 85–91, John W. Kelly, Geoffrey D. Cains, Michael Rallings and Stephen J. Gilmore

    Version of Record online : 28 JUN 2007, DOI: 10.1111/j.1440-0960.1991.tb00071.x

  15. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids

    British Journal of Dermatology

    Volume 157, Issue 5, November 2007, Pages: 954–959, D.F. Murrell, S. Calvieri, J.P. Ortonne, V.C. Ho, S. Weise-Riccardi, N. Barbier and C.F. Paul

    Version of Record online : 11 OCT 2007, DOI: 10.1111/j.1365-2133.2007.08192.x

  16. Linear skin atrophy, scarring alopecia, anonychia, and tongue lesion: A “new” syndrome?

    American Journal of Medical Genetics

    Volume 21, Issue 4, August 1985, Pages: 669–680, Jorge Sequeiros, George H. Sack Jr., John M. Opitz and James F. Reynolds

    Version of Record online : 3 JUN 2005, DOI: 10.1002/ajmg.1320210408

  17. Vulvar Skin Atrophy Induced by Topical Glucocorticoids

    Journal of Midwifery & Women’s Health

    Volume 57, Issue 3, May/June 2012, Pages: 296–299, Elisabeth Johnson, Pamela Groben, Alisa Eanes, Priya Iyer, Joseph Ugoeke and Denniz Zolnoun

    Version of Record online : 18 MAY 2012, DOI: 10.1111/j.1542-2011.2012.00189.x

  18. New aspects of the mechanism of corticosteroid–induced dermal atrophy

    Clinical and Experimental Dermatology

    Volume 16, Issue 6, November 1991, Pages: 416–419, AARNE OIKARINEN and PEKKA AUTIO

    Version of Record online : 27 APR 2006, DOI: 10.1111/j.1365-2230.1991.tb01225.x

  19. Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial

    British Journal of Dermatology

    Volume 155, Issue 4, October 2006, Pages: 700–706, M. Coßmann and J. Welzel

    Version of Record online : 12 JUN 2006, DOI: 10.1111/j.1365-2133.2006.07369.x

  20. You have full text access to this OnlineOpen article
    REDD1 functions at the crossroads between the therapeutic and adverse effects of topical glucocorticoids

    EMBO Molecular Medicine

    Volume 7, Issue 1, January 2015, Pages: 42–58, Gleb Baida, Pankaj Bhalla, Kirill Kirsanov, Ekaterina Lesovaya, Marianna Yakubovskaya, Kit Yuen, Shuchi Guo, Robert M Lavker, Ben Readhead, Joel T Dudley and Irina Budunova

    Version of Record online : 11 DEC 2014, DOI: 10.15252/emmm.201404601